KANGEN

Kangen specializes in working with pharmaceutical companies outside the US through co-development or licensing arrangements to develop their drugs in the US. Through these agreements we obtain exclusive distribution rights, or co-marketing rights for the North American market. We offer a unique perspective on how to develop drugs utilizing various regulatory strategies & platforms with our core team that has decades of experience in developing niche and Orphan Drugs worldwide. Our primary territory is Japan, though we also have partners in other parts of Southeast Asia as well as Europe that desire to bring their products into the North American market... We at Kangen Pharmaceuticals (US) in partnership with Nichi-Iko Group (Japan), are developing advanced therapies to help address unmet medical needs to treat rare diseases in patients We are committed to bringing safe and effective medicines to patients as quickly as possible and believe that participating in clinical trials is the..

Also known as: Kangen Pharma

Primary location: Kansas City United States